Oceania Healthcare (ASX:OCA) announced financial results for the half-year ended 30 September 2022.

Total assets increased to $2.5bn representing 12% growth since 31 March 2022. The increase includes the addition of the Remuera Rise and Bream Bay acquisitions for $57.0m which were completed on 1 July 2022.

Realised gains from new sales and resales up 12% compared with the prior corresponding period, with strong development and resale margin performance.

Enhancements to our bank debt facilities agreement, with an increased facility size from $350m to $500m, an extension of maturity date to FY2028, as well as the inclusion of sustainability linked targets.

127 care suites delivered at Lady Allum in Auckland and Woodlands in Motueka.

519 units and care suites currently under construction in Auckland, Hamilton, Tauranga, Blenheim and Christchurch.

Interim dividend of 1.9 cents per share (not imputed) announced. This will have a record date of 30 November 2022 and will be paid on 14 December 2022. The Dividend Reinvestment Plan will apply to this dividend at a discount of 2.0% to the volume weighted average price of shares sold on the NZX Main Board over a period of five trading days starting on 29 November 2022.

Following the announcement the company?s share price unchanged.